As of May 01
| +0.04 / +0.65%|
The 5 analysts offering 12-month price forecasts for Evoke Pharma Inc have a median target of 19.00, with a high estimate of 25.00 and a low estimate of 14.00. The median estimate represents a +205.96% increase from the last price of 6.21.
The current consensus among 5 polled investment analysts is to Buy stock in Evoke Pharma Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.